GlassScriptPhysician profile
Darren Sachs
NPI 1619318482
$15,508.90
in general payments reported to CMS, 2019-2025
32 companies · $2,577 in 2025
The $2,577 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,515 · 2023: $1,676 · 2024: $9,741 · 2025: $2,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,132 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,776 · Travel and Lodging: $3,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,131.76 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,776.00 |
| Travel and Lodging | $3,086.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $4,201.35 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Leica Microsystems INC. | $4,097.55 | 2022-2024 | Mammotome Revolve |
| Tela Bio, INC. | $2,792.64 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $1,420.50 | 2024-2025 | Irrisept |
| Elucent Medical | $1,232.45 | 2022-2025 | |
| Hologic INC | $542.91 | 2022-2023 | Localizer |
| Hologic Sales and Service, LLC | $243.62 | 2023-2024 | Localizer, Atec, Trident Specimen Radiography System |
| Astrazeneca Pharmaceuticals LP | $148.94 | 2023-2025 | Enhertu, Lynparza |
| Incyte Corporation | $138.95 | 2023-2024 | Jakafi, Monjuvi, Pemazyre |
| Ge Healthcare | $63.64 | 2022 | |
| Glaxosmithkline, LLC. | $54.70 | 2024-2025 | Zejula, Jemperli, Ojjaara |
| Molli Surgical (US) INC | $50.91 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.67 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.61 | 2024-2025 | Ninlaro, Alunbrig |
| Merck Sharp & Dohme LLC | $39.18 | 2024 | Keytruda, Lynparza |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $38.66 | 2023-2024 | Cosela, Monoferric |
| Genentech USA, INC. | $34.94 | 2023-2024 | Tecentriq, Alecensa |
| Adaptive Biotechnologies Corporation | $31.91 | 2025 | Clonoseq |
| W. L. Gore & Associates, INC. | $31.28 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Janssen Biotech, INC. | $29.05 | 2024 | Tecvayli |
| Aveo Pharmaceuticals, INC. | $25.66 | 2024 | |
| Mirati Therapeutics, INC. | $25.03 | 2024 | Krazati |
| Blueprint Medicines Corporation | $21.92 | 2024 | Ayvakit |
| Genmab U.S., INC. | $21.83 | 2025 | Epkinly |
| Astellas Pharma US INC | $21.23 | 2023 | Xospata |
| Davol INC. | $18.10 | 2025 | Phasix Mesh |
| Daiichi Sankyo INC. | $17.90 | 2024 | Enhertu |
| Agios Pharmaceuticals, INC. | $17.63 | 2023 | Pyrukynd |
| Octapharma USA, INC. | $17.22 | 2024 | Panzyga |
| Deciphera Pharmaceuticals INC. | $17.05 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $14.80 | 2024 | Libtayo |
| Alnylam Pharmaceuticals INC. | $14.07 | 2024 | Givlaari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Sachs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.